tbuckley/cabot-search huggingface dataset:
Raising the Bar for Procedural Competency Among Hospitalists
Authors: Joseph G. Weigel
Journal: Annals of Internal Medicine (2019)

Letters1 October 2019Raising the Bar for Procedural Competency Among HospitalistsJoseph G. Weigel, MDJoseph G. Weigel, MDLake Cumberland Regional Hospital, Somerset, Kentucky (J.G.W.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L19-0448 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:I read Crocker and colleagues' commentary (1) with interest. As a generalist in a rural hospital setting who trained in internal medicine more than 30 years ago, maintaining procedural competence was never a question. After finishing training and beginning practice in an area where no subspecialists were available, we had no choice but to master procedural skills. These included airway and ventilator management and obtaining central venous access (such as placing pulmonary artery catheters and temporary pacemakers) if our patients were to survive. It went without saying that we regularly did arthrocentesis, paracentesis, and thoracentesis.I have ...Reference1. Crocker JT, Hale CP, Vanka A, et al. Raising the bar for procedural competency among hospitalists. Ann Intern Med. 2019;170:654-5. [PMID: 31009942]. doi:10.7326/M18-3007 LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Lake Cumberland Regional Hospital, Somerset, Kentucky (J.G.W.)Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0448. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRaising the Bar for Procedural Competency Among Hospitalists Jonathan T. Crocker , Caleb P. Hale , Anita Vanka , Daniel N. Ricotta , Jakob I. McSparron , and Grace C. Huang Raising the Bar for Procedural Competency Among Hospitalists Daniel N. Ricotta , Jakob I. McSparron , and Grace C. Huang Metrics 1 October 2019Volume 171, Issue 7Page: 524KeywordsHospital medicineHospitalistsInpatientsIntensive care unitsPacemakersPulmonary artery cathetersResidencySub-specialty careUltrasound imagingVentilators ePublished: 1 October 2019 Issue Published: 1 October 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Transcriptome signatures of treatment responses in a preoperative window of opportunity trial of nivolumab and tadalafil in resectable squamous cell carcinoma of the head and neck
Authors: S. Shukla, J.M. Johnson, J.M. Curry, Y. Kim, A. Argiris, A. Luginbuhl, L. Harshyne, U. Rodeck
Journal: Annals of Oncology (2019)
Abstract 6: The Induction of Mild Hypothermia Prevents Acute Respiratory Failure During Endotoxemia in Pigs
Authors: Michael Schwarzl, Sebastian Seiler, Stefan Huber, Paul Steendijk, Heinrich Mächler, Martini Truschnig-Wilders, Burkert Pieske, Heiner Post
Journal: Circulation (2011)

Background: Acute respiratory failure is a major component of multi-organ failure during sepsis. The induction of mild hypothermia (MH, 33 °C) reduces whole body oxygen demand and exerts anti-inflammatory effects in experimental settings. We tested the effect of MH on respiratory function during experimental endotoxemia in pigs. Methods: Anesthetized pigs (65±2 kg) were acutely instrumented (closed chest) with a series of catheters (Swan-Ganz catheter, left ventricular pressure-volume catheter, intravascular cooling device). Pigs were ventilated in a volume controlled mode at a tidal volume of 10 ml/kg (FiO2 50%). Respiratory rate was adjusted to keep end-tidal pCO2 between 40 and 45 mmHg. Endotoxemia, a model of septic shock, was induced by lipopolysaccharid (LPS) infusion at 0.5 µg/kg/h for 1h and 1 µg/kg/h for further 3h. With the beginning of LPS infusion, pigs were assigned to either normothermia (NT, 38 °C, n=7) or MH (33 °C, n=6) and followed for a total of 8 hours. Data are reported at 8h after onset of LPS-infusion vs baseline. *: p&lt;0.05 vs baseline, †: p&lt;0.05 vs NT. Results: Heart rate (bpm) increased in NT (128±6* vs 97±4), but decreased in MH (79±4*,† vs 98±4). Mean aortic pressure (mmHg) decreased to the same degree in NT (53±4* vs 86±2) and MH (58±1* vs 85±2). Whole body oxygen consumption (WB-VO2) increased during LPS infusion in NT but fell markedly in MH (see graph). Respiratory minute volume (RMV) changed accordingly in the two groups. Moreover, arterial oxygen saturation (sO2,art) fell significantly in NT but was almost completely preserved in MH. Conclusion: MH prevents acute respiratory failure during endotoxemia. This may relate to (i) reduced systemic oxygen demand with subsequently less mechanical pulmonary stress associated with mechanical ventilation and (ii) a direct anti-inflammatory effect of MH that preserves the lungs capability to oxygenate blood. These data imply that MH may be a therapeutic option for acute pulmonary failure during sepsis.
Lurbinectedin (LUR) in combination with irinotecan (IRI) in patients (pts) with advanced solid tumours
Authors: S Ponce Aix, M.J. Flor, A. Falcón, I Sánchez Simón, E. Jimenez, G. Coté, R. Nuñez, M. Siguero, M. Insa, M. Cullell-Young, C. Kahatt, A. Zeaiter, L. Paz-Ares
Journal: Annals of Oncology (2019)
Hospitalized Women With Cirrhosis Have More Nonhepatic Comorbidities and Associated Complications Than Men
Authors: Jessica B. Rubin, Yanin T. Srisengfa, Somaya Albhaisi, Chathur Acharya, Gayatri Nangia, Tahira Shaikh, Leroy R. Thacker, K. Rajender Reddy, Puneeta Tandon, Jasmohan S. Bajaj, Jennifer C. Lai
Journal: Clinical Gastroenterology and Hepatology (2019)
Factors influencing the level of emotional support from nurses perceived by patients undergoing haematopoietic stem cell transplantation in protective isolation
Authors: M. Piredda, V. Biagioli, G. Gargiulo, O. Annibali, M.C. Tirindelli, A. Pignatelli, F. Marchesi, M.R. Mauroni, S. Soave, E. Del Giudice, E. Ponticelli, M. Clari, S. Cavallero, P. Monni, L. Ottani, S. Sica, M. Cioce, L. Cappucciati, R. Alvaro, M.G. De Marinis
Journal: Annals of Oncology (2019)
Abstract 19172: Genetic Mosaicism in Calmodulinopathy Associated With a Novel CALM3 Mutation
Authors: Lisa M Wren, Juan Jimenez-Jaimez, Franck Potet, Christopher N Johnson, Tatiana V Abramova, Defne E Egecioglu, Paul Burridge, Walter Chazin, Alfred L George
Journal: Circulation (2017)

Introduction: Calmodulin (CaM) mutations are associated with congenital arrhythmia susceptibility (calmodulinopathy). We identified a novel mutation (E141K) in CALM3 associated with ventricular arr...
HAND DISINFECTION.
Authors: Robert Purves
Journal: JAMA (1892)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Molecular characterization of metastatic urothelial carcinoma (mUC) in prior or current smokers (PCS) vs non-smokers (NS)
Authors: V. Sacristan Santos, J. Esther, B.L. Maughan, S. Wesolowski, E. Lin, A. Hahn, D. Sirohi, N. Rathi, U. Swami, R. Nussenzveig, N. Agarwal
Journal: Annals of Oncology (2019)
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial
Authors: Nadine G. Rouphael, Cecilia Morgan, Shuying S. Li, Ryan Jensen, Brittany Sanchez, Shelly Karuna, Edith Swann, Magdalena E. Sobieszczyk, Ian Frank, Gregory J. Wilson, Hong-Van Tieu, Janine Maenza, Aliza Norwood, James Kobie, Faruk Sinangil, Giuseppe Pantaleo, Song Ding, M. Juliana McElrath, Stephen C. De Rosa, David C. Montefiori, Guido Ferrari, Georgia D. Tomaras, Michael C. Keefer
Journal: Journal of Clinical Investigation (2019)

BACKGROUND. RV144 is the only preventive HIV vaccine regimen demonstrating efficacy in humans. Attempting to build upon RV144 immune responses, we conducted a phase 1, multicenter, randomized, double-blind trial to assess the safety and immunogenicity of regimens substituting the DNA-HIV-PT123 (DNA) vaccine for ALVAC-HIV in different sequences or combinations with AIDSVAX B/E (protein).
A Phase I/II Study of Chemosensitization with the CXCR4 Antagonist Plerixafor in Relapsed or Refractory AML.
Authors: Geoffrey L. Uy, Michael P. Rettig, Kyle McFarland, Lindsay Hladnik, Shashikant Kulkarni, Camille N. Abboud, Amanda F Cashen, Keith Stockerl-Goldstein, Ravi Vij, Peter Westervelt, John F. DiPersio
Journal: Blood (2009)
Quality of life of metastatic urothelial cancer (mUC) patients treated with enfortumab vedotin (EV) following platinum-containing chemotherapy and a checkpoint inhibitor (CPI): Data from EV-201 cohort 1
Authors: B.A. McGregor, P.H. O’Donnell, A. Balar, D.P. Petrylak, J.E. Rosenberg, E. Yu, D.I. Quinn, S.N. Shah, J. Pinelli, Z. Hepp, M. Galsky
Journal: Annals of Oncology (2019)
Meta-analysis on association of pathological complete response with long-term survival outcomes in triple-negative breast cancer
Authors: P.A. Fasching, M. Huang, J. Cortés, J. Zhao, J. O’Shaughnessy, P. Hu, A. Haiderali, V. Karantza, G. Aktan, A. Briggs, S. Ramsey, C.Z. Qi, J. Xie, C. Gu, K. Qian, M. Yuan, E.Q. Wu
Journal: Annals of Oncology (2019)
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma
Authors: Shailender Bhatia, Natalie V. Longino, Natalie J. Miller, Rima Kulikauskas, Jayasri G. Iyer, Dafina Ibrani, Astrid Blom, David R. Byrd, Upendra Parvathaneni, Christopher G. Twitty, Jean S. Campbell, Mai H. Le, Sharron Gargosky, Robert H. Pierce, Richard Heller, Adil I. Daud, Paul Nghiem
Journal: Clinical Cancer Research (2019)

Abstract Purpose: IL12 promotes adaptive type I immunity and has demonstrated antitumor efficacy, but systemic administration leads to severe adverse events (AE), including death. This pilot trial investigated safety, efficacy, and immunologic activity of intratumoral delivery of IL12 plasmid DNA (tavo) via in vivo electroporation (i.t.-tavo-EP) in patients with Merkel cell carcinoma (MCC), an aggressive virus-associated skin cancer. Patients and Methods: Fifteen patients with MCC with superficial injectable tumor(s) received i.t.-tavo-EP on days 1, 5, and 8 of each cycle. Patients with locoregional MCC (cohort A, N = 3) received one cycle before definitive surgery in week 4. Patients with metastatic MCC (cohort B, N = 12) received up to four cycles total, administered at least 6 weeks apart. Serial tumor and blood samples were collected. Results: All patients successfully completed at least one cycle with transient, mild (grades 1 and 2) AEs and without significant systemic toxicity. Sustained (day 22) intratumoral expression of IL12 protein was observed along with local inflammation and increased tumor-specific CD8+ T-cell infiltration, which led to systemic immunologic and clinical responses. The overall response rate was 25% (3/12) in cohort B, with 2 patients experiencing durable clinical benefit (16 and 55+ months, respectively). Two cohort A patients (1 with pathologic complete remission) were recurrence-free at 44+ and 75+ months, respectively. Conclusions: I.t.-tavo-EP was safe and feasible without systemic toxicity. Sustained local expression of IL12 protein and local inflammation led to systemic immune responses and clinically meaningful benefit in some patients. Gene electrotransfer, specifically i.t.-tavo-EP, warrants further investigation for immunotherapy of cancer.
A nomogram based prognostic score to predict overall survival (OS) in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
Authors: L. Mousa, M. Issa, B. Klamer, J. Pan, M. Old, S. Kang, A. Agrawal, E. Ozer, R. Carrau, P. Bhateja, R. Rupert, S. Jhawar, D. Mitchell, M. Gamez, J. Rocco, D. Blakaj, M.R. Bonomi
Journal: Annals of Oncology (2019)
Uncommon Metastasis to the Pancreas From Adenocarcinoma of the Cervix Detected on Surveillance 18F-FDG PET/CT Imaging
Authors: Sonia Mahajan, Neeta Pandit-Taskar
Journal: Clinical Nuclear Medicine (2017)

F-FDG PET/CT is a sensitive noninvasive imaging tool for assessment of recurrent disease in patients with carcinoma cervix. Its role in early detection of recurrences especially in asymptomatic patients has been demonstrated well in literature. Metastatic involvement of the pancreas in patients with adenocarcinoma of the cervix is a rare occurrence, reported only few times in literature, and is predominantly documented to be associated with uncommon histopathologies such as neuroendocrine and small cell carcinoma. We report a rare asymptomatic case of adenocarcinoma of the cervix, detected and confirmed to have pancreatic metastasis on surveillance FDG PET/CT imaging.
Aspirin and NSAID use and keratinocyte cancers
Authors: N. Pandeya, C.M. Olsen, B.S. Thompson, J.C. Dusingize, R.E. Neale, A.C. Green, D.C. Whiteman
Journal: British Journal of Dermatology (2019)

It is thought that aspirin and other nonsteroidal anti‐inflammatory drugs (NSAIDS) may protect against keratinocyte skin cancers, i.e. squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). However, the evidence for this is scant. The authors, based in Queensland, Australia, studied a group of middle‐aged or elderly Queensland residents obtained from the register of voters (the QSkin study). They compared the incidence of keratinocyte cancers in a three‐year period in individuals who self‐reported taking aspirin or another NSAID regularly, with those who did not. In patients at high risk (such as having a history of previous skin cancer or multiple patches on the skin called actinic lesions) they found that taking aspirin infrequently (less than once a week) was associated with a slightly reduced risk of SCC. Regular use of other NSAIDS (at least once a week) led to a slightly reduced risk of BCCs. In low‐risk patients (no history of skin cancer and fewer than 5 actinic lesions) the authors found no reduced risk from taking aspirin or other NSAIDs. The authors comment that many patients are on low dose aspirin to reduce the risk of heart attacks or strokes, but this may be inadequate to prevent skin cancer. As most patients purchase non‐steroidal drugs over the counter, it was not possible to determine dosage and duration of treatment. They conclude that the protective effect of NSAIDS is slight and only of value in patients at high risk.
Clinical outcomes by sex with atezolizumab (atezo) monotherapy in patients (pts) with locally advanced/metastatic urothelial carcinoma (mUC)
Authors: J. Hoffman-Censits, J.E. Rosenberg, M. van Der Heijden, R. Dreicer, J.L. Perez Gracia, D.P. Petrylak, M.M. Retz, R. Sabbatini, E. Naglieri, C. Caserta, M. Maruzzo, R. Iacovelli, L. Galli, R. McDermott, R. Morales Barrera, T. Bonfill, S. De Ducla, B. Ding, J. Linsenmeier, C.N. Sternberg
Journal: Annals of Oncology (2019)
SAKK 17/16 - Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm phase II trial
Authors: Y. Metaxas, M. Frueh, E.I. Eboulet, F. Grosso, M. Pless, P.A. Zucali, G.L. Ceresoli, M.T. Mark, M. Schneider, A. Roveta, M.R.A. Perrino, C. Biaggi Rudolf, P.R. Froesch, S. Schmidt, C. Waibel, C. Appenzeller, D. Rauch, R. von Moos
Journal: Annals of Oncology (2019)
Pembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study
Authors: D. O'Malley, A. Marabelle, A. De Jesus-Acosta, S.A. Piha-Paul, A. Arkhipov, F. Longo, D. Motola-Kuba, R. Shapira-Frommer, R. Geva, B.J. Rimel, J.A. Lopez-Martin, A.R. Hansen, J.M. Mehnert, X. Chen, F. Jin, K. Norwood, P.A. Ott
Journal: Annals of Oncology (2019)
The Ethical Dilemma of whether a Gastroenterologist Must Inform a Patient in every Case about a Fatal Illness
Authors: B Novis
Journal: Endoscopy (2006)

Case l: An 83-year-old minister of religion has been diagnosed (biopsy proven) as having an inoperable pancreatic cancer. He has a strong family history of gastrointestinal cancers and has tended to have episodes of depression, requiring psychiatric treatment in the past. His three daughters and two sons vehemently oppose telling their father either the diagnosis or the prognosis.
FGFR2 fusions and its effect of patient (pt) outcomes in intrahepatic cholangiocarcinoma (iCCA)
Authors: D.R. Almquist, M. Javle, K.K. Ciombor, M. Roth, R. Abdel-Wahab, F.-S. Ou, E. Wolfe, K. Mody, A. Mahipal, M.J. Borad, T. Bekaii-Saab, D. Ahn
Journal: Annals of Oncology (2019)
Adjuvant nivolumab (NIVO) versus ipilimumab (IPI) in resected stage III/IV melanoma: 3-year efficacy and biomarker results from the phase III CheckMate 238 trial
Authors: J.S. Weber, M. Del Vecchio, M. Mandala, H. Gogas, A.M. Arance, S. Dalle, C.L. Cowey, M. Schenker, J.J. Grob, V. Chiarion-Sileni, I. Marquez-Rodas, M.O. Butler, M. Maio, M.R. Middleton, T. Tang, A. Saci, V. De Pril, M. Lobo, J.M.G. Larkin, P.A. Ascierto
Journal: Annals of Oncology (2019)
Low- and high-thermogenic brown adipocyte subpopulations coexist in murine adipose tissue
Authors: Anying Song, Wenting Dai, Min Jee Jang, Leonard Medrano, Zhuo Li, Hu Zhao, Mengle Shao, Jiayi Tan, Aimin Li, Tinglu Ning, Marcia M. Miller, Brian Armstrong, Janice M. Huss, Yi Zhu, Yong Liu, Viviana Gradinaru, Xiwei Wu, Lei Jiang, Philipp E. Scherer, Qiong A. Wang
Journal: Journal of Clinical Investigation (2019)

Brown adipose tissue (BAT), as the main site of adaptive thermogenesis, exerts beneficial metabolic effects on obesity and insulin resistance. BAT has been previously assumed to contain a homogeneous population of brown adipocytes. Utilizing multiple mouse models capable of genetically labeling different cellular populations, as well as single-cell RNA sequencing and 3D tissue profiling, we discovered a brown adipocyte subpopulation with low thermogenic activity coexisting with the classical high-thermogenic brown adipocytes within the BAT. Compared with the high-thermogenic brown adipocytes, these low-thermogenic brown adipocytes had substantially lower Ucp1 and Adipoq expression, larger lipid droplets, and lower mitochondrial content. Functional analyses showed that, unlike the high-thermogenic brown adipocytes, the low-thermogenic brown adipocytes have markedly lower basal mitochondrial respiration, and they are specialized in fatty acid uptake. Upon changes in environmental temperature, the 2 brown adipocyte subpopulations underwent dynamic interconversions. Cold exposure converted low-thermogenic brown adipocytes into high-thermogenic cells. A thermoneutral environment had the opposite effect. The recruitment of high-thermogenic brown adipocytes by cold stimulation is not affected by high-fat diet feeding, but it does substantially decline with age. Our results revealed a high degree of functional heterogeneity of brown adipocytes.
Abstract 20889: Impaired Chronotropic Response to Exercise in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus
Authors: Sangyeub Lee, Goo Joo Lee, Jang-Whan Bae, Kyung-Kuk Hwang
Journal: Circulation (2017)

Purpose: The aim of this study was to identify impaired chronotropic response to exercise during cardiopulmonary exercise test after acute myocardial infarction(AMI) in patients with type 2 diabete...
Factors of importance in procuring tumoroids from colorectal liver metastasis biopsies for precision medicine
Authors: L.H. Jensen, C. Dam, G. Hagel, C. Vagn-Hansen, H. Harling, B.M. Havelund, A. Jakobsen, J. Lindebjerg, S.R. Rafaelsen, O. Thastrup, T.F. Hansen
Journal: Annals of Oncology (2019)
Advanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany
Authors: P.J. Goebell, L. Mueller, C. Grüllich, D. Reichert, M. Bögemann, S. Dörfel, E. von der Heyde, A. Binninger, M. Jänicke, M. Merling, N.W. Marschner, M. Staehler, V. Grünwald
Journal: Annals of Oncology (2019)
Blood-based testing of mutations in patients with head and neck squamous cell carcinoma (HNSCC) using highly sensitive SafeSEQ technology
Authors: F. Fostira, P. Oikonomopoulou, A. Kladi, D. Edelstein, K. Stieler, D. Heim, M. Gkotzamanidou, M. Anastasiou, I. Kotsantis, G. Kavourakis, N. Gavrielatou, E. Kousidou, E.V. Vagia, F. Holtrup, A. Psyrri
Journal: Annals of Oncology (2019)
LONG-TERM OUTCOME OF EARLY GASTRIC CANCER WITH LATERAL MARGIN POSITIVE AFTER ENDOSCOPIC RESECTION
Authors: H Kim, DH Yang, BW Bang, KS Kwon, YW Shin
Journal: Endoscopy (2019)

The positive lateral margin after endoscopic resection (ER) of early gastric cancer (EGC), additional surgery or endoscopic submucosal dissection (ESD) are recommended. However, the additional surgery often difficult due to advanced age or patient's comorbid conditions. The aims of this study is to investigate of long term outcome in patients with positive lateral margin after ER.
AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors
Authors: T. Gruosso, M. O’Connor, J.-F. Denis, R. Figueredo, J. Koropatnick, G. Tremblay, I.A. Tikhomirov
Journal: Annals of Oncology (2019)
Incidence of T790M in NSCLC patients progressed to gefitinib, erlotinib, and afatinib: A study on circulating tumour DNA
Authors: R. Danesi, I. Petrini, F. Mazzoni, S. Valleggi, G. Gianfilippo, D. Pozzessere, S. Crucitta, G. Restante, A. Chella, M.C. Garassino, M. Miccoli, M.l. De Re
Journal: Annals of Oncology (2019)
Molecular fingerprinting in breast cancer (BC) screening using Quantum Optics (QO) technology combined with an artificial intelligence (AI) approach applying the concept of “molecular profiles at n variables (MPnV)”: A prospective pilot study
Authors: J-M A Nabholtz, K.A. Alsaleh, S. Kullab, N. Abdel-Aziz, A. Abdelwarith, A Al Diab, M.A. Hilal, F. Dabouz, V. Bajic, R. Incitti, M.R.K. Bahadoor, A.M. Azeer
Journal: Annals of Oncology (2019)